Close

BIO Industry Analysis Investor Survey: FDA Approvals Expected to Increase and Majority of Investors Believe Now is a Good Time to Invest in Biotech

Feb 15 2012
Survey data released at 14thAnnual BIO CEO & Investor Conference in New York City.

Administration‘s 2013 Budget Could Discourage Development of Cures and Breakthrough Medicines, Limit Patient Choice And Forestall Job Growth

Feb 14 2012
“The biotechnology industry has long been an engine for economic development and job creation across the country and our sector is working to add more high-wage high-skilled jobs to our workforce." 

BIO’s 9th Annual World Congress on Industrial Biotechnology and Bioprocessing in Orlando to Feature Presentations on Advanced Biofuels and Renewable Chemicals

Feb 9 2012
“We are excited to bring this conference to Orlando to highlight the industry's growth, the importance of this industrial and environmental biotechnology for generating green jobs, making greener products and cleaner processes all aimed at building a biobased economy." 

Release of FDA Guidance for Biosimilars Pathway Marks Important Step Forward, Says BIO

Feb 9 2012
BIO President and CEO Jim Greenwood issued the following statement regarding the newly released U.S. Food and Drug Administration (FDA) guidance for the review and approval of biosimilars.

More Farmers Favor Biotech Crops

Feb 7 2012
Because of their tremendous environmental and economic benefits, farmers around the world continue to adopt genetically engineered (GE) crops according to a report released today by the International Service for the Acquisition of Agri-Biotech Applications (ISAAA). 

BIO Testifies on Importance of Prompt Enactment of PDUFA V Recommendations

Feb 1 2012
In the testimony, Richard Pops, Alkermes plc Chairman and CEO,  stressed the need for a quick reauthorization of the Prescription Drug User Fee Act (PDUFA) and enactment of the enhancements recommended in the PDUFA V agreement. 

14th Annual BIO CEO & Investor Conference to Highlight 2012 Investment Outlook, New Business Models and Key Therapeutic Topics

Jan 30 2012
The Biotechnology Industry Organization (BIO) announces plenary sessions, Business Roundtables and Therapeutic Workshops selected for the 14th Annual BIO CEO & Investor Conference.

BIO Congratulates ZeaChem, Applauds USDA Loan Guarantee Announcement

Jan 26 2012
The USDA's loan guarantee program is helping advanced biofuel companies attract necessary financing for commercial projects. Projects like ZeaChem's can bring jobs and economic growth to rural areas.

Biotechnology Can Provide Foundation for A U.S. Economy “Built To Last”

Jan 25 2012
BIO calls on the administration and Congress to embrace proposals to Unleash the Promise of Biotechnology.

2012 BIO International Convention to Highlight Insights from Senior Biotech Executives on Latest Trends, Emerging Policy, and Business Development Issues

Jan 25 2012
The 2012 BIO International Convention will feature a program packed with more than 125 breakout sessions.